| # | Name | Price | 24h % | 7d % | Market Cap | Volume (24h) | Last 7 Days |
|---|---|---|---|---|---|---|---|
| 701 | ¥50.51 | -4.10% | +7.06% | ¥5.66B $780.68M · €680.68M | 1.94M shrs ¥98.22M | ||
| 702 | ¥11.29 | +0.09% | -0.58% | ¥5.65B $779.46M · €679.61M | 3.36M shrs ¥37.98M | ||
| 703 | ¥5.17 | -5.31% | +2.62% | ¥5.65B $779.02M · €679.23M | 111.5M shrs ¥576.45M | ||
| 704 | $7.50 | -6.48% | +22.22% | $776.38M €676.93M | 1.22M shrs $9.15M | ||
| 705 | $8.74 | -0.34% | +3.85% | $775.89M €676.50M | 3.22M shrs $28.16M | ||
| 706 | $16.43 | -3.35% | -10.46% | $775.07M €675.78M | 386.84K shrs $6.36M | ||
| 707 | ¥13.49 | +1.28% | +4.20% | ¥5.61B $774.81M · €675.55M | 2.2M shrs ¥29.74M | ||
| 708 | kr 76.70 | +1.46% | +0.60% | kr 7.98B $774.28M · €675.09M | 237.7K shrs kr 18.23M | ||
| 709 | ¥6.70 | +0.15% | -2.29% | ¥5.57B $768.46M · €670.02M | 5.15M shrs ¥34.51M | ||
| 710 | HK$4.09 | -0.24% | +4.68% | HK$6B $768.16M · €669.76M | 168K shrs HK$687.12K | ||
| 711 | ¥37.25 | -1.40% | -4.63% | ¥5.56B $767.65M · €669.31M | 1.28M shrs ¥47.82M | ||
| 712 | HK$9.03 | -1.95% | +20.52% | HK$5.99B $766.99M · €668.74M | 1.7M shrs HK$15.35M | ||
| 713 | ₩46000.00 | +0.88% | +2.01% | ₩1.06T $764.86M · €666.88M | 123 shrs ₩5.66M | ||
| 714 | C$18.32 | -2.60% | +5.05% | C$1.03B $762.77M · €665.06M | 87.01K shrs C$1.59M | ||
| 715 | HK$23.94 | -0.08% | +1.27% | HK$5.91B $757.02M · €660.05M | 1.11M shrs HK$26.49M | ||
| 716 | ¥3180.00 | +1.11% | -2.16% | ¥112.73B $755.29M · €658.54M | 39.5K shrs ¥125.61M | ||
| 717 | ¥21.87 | -0.95% | -25.01% | ¥5.47B $754.86M · €658.17M | 5.24M shrs ¥114.5M | ||
| 718 | ¥2.74 | +1.48% | +6.64% | ¥5.46B $753.54M · €657.01M | 12.53M shrs ¥34.34M | ||
| 719 | ₹237.35 | -10.89% | +3.32% | ₹62.59B $751.13M · €654.91M | 2.97M shrs ₹704.98M | ||
| 720 | ¥35.18 | -1.35% | +0.93% | ¥5.44B $751.11M · €654.89M | 5.54M shrs ¥194.85M | ||
| 721 | $1.17 | -3.31% | -5.93% | $750.58M €654.43M | 9.5M shrs $11.12M | ||
| 722 | NT$50.40 | +0.40% | +6.58% | NT$24.16B $748.98M · €653.03M | 1.57M shrs NT$79.27M | ||
| 723 | MX$14.70 | -4.11% | +8.74% | MX$14.37B $747.39M · €651.65M | 3.9M shrs MX$57.32M | ||
| 724 | HK$6.97 | -0.14% | -0.92% | HK$5.83B $746.83M · €651.16M | 767K shrs HK$5.35M | ||
| 725 | $2.68 | -9.46% | +6.27% | $745.82M €650.28M | 4.61M shrs $12.36M | ||
| 726 |  FDC Limited FDC.NS🇮🇳INR | ₹381.00 | -4.88% | +4.48% | ₹62.03B $744.37M · €649.01M | 630.99K shrs ₹240.41M | |
| 727 |  FDC Limited FDC.BO🇮🇳INR | ₹380.75 | -5.04% | +6.76% | ₹61.99B $743.88M · €648.59M | 28.41K shrs ₹10.82M | |
| 728 | ¥23.66 | +0.00% | -6.68% | ¥5.37B $740.52M · €645.66M | 874.52K shrs ¥20.69M | ||
| 729 | ¥5.06 | -1.94% | +8.61% | ¥5.34B $737.32M · €642.87M | 20.77M shrs ¥105.11M | ||
| 730 | ¥5.10 | +0.59% | +1.59% | ¥5.33B $736.17M · €641.87M | 5.17M shrs ¥26.38M | ||
| 731 | ¥37.45 | -2.58% | +11.09% | ¥5.22B $719.77M · €627.57M | 1.85M shrs ¥69.22M | ||
| 732 |  Evommune, Inc. EVMN🇺🇸USD | $19.92 | -3.72% | -47.13% | $717.49M €625.58M | 417.27K shrs $8.31M | |
| 733 | ¥3.99 | +0.50% | +34.56% | ¥5.18B $714.36M · €622.85M | 22.1M shrs ¥88.18M | ||
| 734 | ¥5.21 | -1.14% | -1.43% | ¥5.17B $713.45M · €622.05M | 14.9M shrs ¥77.61M | ||
| 735 | $13.16 | -8.10% | +23.84% | $713.09M €621.74M | 594.49K shrs $7.82M | ||
| 736 | $9.79 | -4.49% | -10.21% | $708.55M €617.79M | 1.68M shrs $16.45M | ||
| 737 | ₩74400.00 | -0.93% | +1.78% | ₩980.3B $705.82M · €615.40M | 27.98K shrs ₩2.08B | ||
| 738 | ₩26350.00 | -4.70% | -6.84% | ₩979.86B $705.50M · €615.13M | 82.84K shrs ₩2.18B | ||
| 739 | ₩10160.00 | -7.13% | -2.70% | ₩975.75B $702.54M · €612.55M | 1.75M shrs ₩17.81B | ||
| 740 | ¥23.04 | +0.35% | +14.47% | ¥5.08B $700.58M · €610.83M | 1.72M shrs ¥39.57M | ||
| 741 | $15.70 | -7.76% | +8.69% | $697.91M €608.51M | 375.92K shrs $5.9M | ||
| 742 | ₩21450.00 | -0.23% | -0.55% | ₩969B $697.68M · €608.31M | 232 shrs ₩4.98M | ||
| 743 | ¥3405.00 | +3.65% | +1.51% | ¥103.78B $695.34M · €606.26M | 82.6K shrs ¥281.25M | ||
| 744 | ¥12.04 | +0.25% | +4.75% | ¥5.03B $693.84M · €604.96M | 1.5M shrs ¥18.07M | ||
| 745 | ¥6.45 | -1.68% | -12.31% | ¥5B $689.76M · €601.40M | 16.87M shrs ¥108.83M | ||
| 746 | ¥8.61 | +0.94% | -4.29% | ¥4.99B $689.01M · €600.75M | 4.9M shrs ¥42.22M | ||
| 747 | ¥8.70 | +0.00% | +4.30% | ¥4.99B $689.01M · €600.75M | 43.86M shrs ¥381.58M | ||
| 748 | $13.10 | -3.75% | -3.03% | $688.61M €600.40M | 1.76M shrs $23.01M | ||
| 749 | $6.63 | -2.50% | -4.13% | $685.45M €597.65M | 345.6K shrs $2.29M | ||
| 750 | ₹629.45 | -2.21% | +3.64% | ₹57.06B $684.77M · €597.05M | 11.12K shrs ₹7M | ||
| 751 | ¥10.07 | +0.70% | -2.07% | ¥4.96B $684.00M · €596.38M | 2.85M shrs ¥28.68M | ||
| 752 | £8.50 | -4.49% | -10.00% | £538.27M $683.60M · €596.03M | 358.87K shrs £3.05M | ||
| 753 | ₹628.30 | -2.40% | -1.25% | ₹56.96B $683.52M · €595.96M | 273.74K shrs ₹171.99M | ||
| 754 | ¥33.17 | -0.66% | +8.51% | ¥4.93B $680.76M · €593.55M | 1.06M shrs ¥35.16M | ||
| 755 | ₩12310.00 | -4.05% | -6.41% | ₩940.81B $677.38M · €590.61M | 315.6K shrs ₩3.88B | ||
| 756 | $69.00 | -7.38% | +2.16% | $677.03M €590.30M | 711.6K shrs $49.1M | ||
| 757 |  Oculis Holding AG OCS🇺🇸USD | $11.21 | -5.24% | +15.44% | $676.95M €590.23M | 869.28K shrs $9.74M | |
| 758 | ¥30.44 | -2.15% | +0.49% | ¥4.84B $667.96M · €582.39M | 3.68M shrs ¥112.1M | ||
| 759 | $10.65 | -1.02% | +6.70% | $665.17M €579.96M | 777.87K shrs $8.28M | ||
| 760 | ¥24.04 | +0.50% | +3.35% | ¥4.79B $661.62M · €576.86M | 877.31K shrs ¥21.09M | ||
| 761 | ¥1265.00 | +0.32% | +5.54% | ¥98.72B $661.44M · €576.71M | 819.6K shrs ¥1.04B | ||
| 762 | ₹237.15 | -10.98% | — | ₹55.01B $660.09M · €575.53M | 181.01K shrs ₹42.93M | ||
| 763 | $6.70 | -7.46% | +16.04% | $659.61M €575.12M | 701.82K shrs $4.7M | ||
| 764 | ¥16.68 | -1.88% | -3.90% | ¥4.76B $657.07M · €572.90M | 9.58M shrs ¥159.81M | ||
| 765 |  CorMedix Inc. CRMD🇺🇸USD | $8.36 | -2.11% | -1.51% | $655.86M €571.84M | 901.06K shrs $7.53M | |
| 766 | $3.00 | -5.66% | +14.29% | $653.11M €569.45M | 3.42M shrs $10.25M | ||
| 767 | ¥43.50 | -6.09% | +16.18% | ¥4.71B $650.06M · €566.79M | 6.38M shrs ¥277.51M | ||
| 768 | $1.88 | -7.84% | +1.93% | $648.89M €565.77M | 7.93M shrs $14.92M | ||
| 769 | ¥1.77 | +4.73% | -8.78% | ¥4.66B $642.68M · €560.35M | 138.54M shrs ¥245.21M | ||
| 770 | $18.26 | -8.84% | +2.05% | $640.82M €558.73M | 395.11K shrs $7.21M | ||
| 771 |  Adlai Nortye Ltd. ANL🇺🇸USD | $9.95 | -9.55% | +0.00% | $640.76M €558.68M | 147.12K shrs $1.46M | |
| 772 | NT$379.00 | -0.39% | +0.53% | NT$20.64B $639.89M · €557.92M | 2.04K shrs NT$773.54K | ||
| 773 | ¥33.18 | -2.53% | +6.17% | ¥4.63B $639.14M · €557.27M | 5.24M shrs ¥174M | ||
| 774 | ¥28.88 | +0.14% | -8.24% | ¥4.62B $637.67M · €555.98M | 8.76M shrs ¥253.04M | ||
| 775 | ¥7.94 | +0.25% | +5.64% | ¥4.62B $637.37M · €555.72M | 11.33M shrs ¥89.98M | ||
| 776 | ¥4.19 | +0.24% | +0.49% | ¥4.56B $628.87M · €548.31M | 15.95M shrs ¥66.81M | ||
| 777 | $18.78 | -3.54% | -1.02% | $627.88M €547.45M | 77.45K shrs $1.45M | ||
| 778 | $10.61 | -5.01% | +6.23% | $627.21M €546.87M | 2.02M shrs $21.46M | ||
| 779 | $7.81 | -5.10% | +4.00% | $625.64M €545.49M | 303.1K shrs $2.37M | ||
| 780 | C$8.61 | +1.77% | +5.80% | C$845.32M $625.54M · €545.41M | 217.63K shrs C$1.87M | ||
| 781 | $5.95 | -5.71% | -5.61% | $624.1M €544.15M | 1.24M shrs $7.35M | ||
| 782 | ¥11.64 | -1.69% | -9.31% | ¥4.52B $624.08M · €544.14M | 12.35M shrs ¥143.7M | ||
| 783 | $8.51 | -8.20% | +8.81% | $623.53M €543.66M | 2.04M shrs $17.35M | ||
| 784 | ¥2103.00 | +1.06% | +0.20% | ¥92.7B $621.08M · €541.52M | 58.3K shrs ¥122.6M | ||
| 785 | ¥12.62 | +1.53% | -2.83% | ¥4.5B $620.96M · €541.42M | 2.69M shrs ¥33.92M | ||
| 786 | ₩53000.00 | -0.93% | -0.25% | ₩861.7B $620.43M · €540.95M | 195.55K shrs ₩10.36B | ||
| 787 | ¥46.49 | +0.24% | +6.49% | ¥4.49B $619.63M · €540.25M | 1.43M shrs ¥66.55M | ||
| 788 | ¥14.40 | +0.35% | +0.82% | ¥4.45B $613.97M · €535.32M | 1.42M shrs ¥20.49M | ||
| 789 | ¥3.73 | +0.27% | -2.22% | ¥4.44B $612.39M · €533.95M | 6.63M shrs ¥24.74M | ||
| 790 | ¥996.00 | +6.64% | -0.83% | ¥91.36B $612.14M · €533.73M | 1.34M shrs ¥1.34B | ||
| 791 | $6.29 | +1.62% | +6.36% | $610.31M €532.13M | 137.5K shrs $864.86K | ||
| 792 | C$6.89 | -4.57% | -2.15% | C$824.07M $609.81M · €531.70M | 987.84K shrs C$6.81M | ||
| 793 | $4.36 | -7.43% | +8.54% | $608.93M €530.93M | 928.85K shrs $4.05M | ||
| 794 |  Climb Bio Inc CLYM🇺🇸USD | $10.55 | -3.30% | +8.05% | $604.12M €526.74M | 985.56K shrs $10.4M | |
| 795 | ¥8.48 | -0.35% | +8.96% | ¥4.35B $600.70M · €523.75M | 8.06M shrs ¥68.36M | ||
| 796 | ¥47.89 | -0.75% | +14.71% | ¥4.35B $600.63M · €523.69M | 977.28K shrs ¥46.8M | ||
| 797 | NT$115.00 | -0.43% | -0.50% | NT$19.26B $597.09M · €520.60M | 334.82K shrs NT$38.5M | ||
| 798 | ₹867.50 | -0.58% | +4.10% | ₹49.64B $595.71M · €519.40M | 24.35K shrs ₹21.13M | ||
| 799 | ¥28.07 | +1.63% | -9.44% | ¥4.31B $594.21M · €518.10M | 1.59M shrs ¥44.69M | ||
| 800 | ¥9.82 | +0.92% | +9.48% | ¥4.31B $594.12M · €518.01M | 23.07M shrs ¥226.51M |
Browse by Country
Europe
Asia